We’re delighted to introduce you to Lyndal Walker, the newest member of Ontario Genomics’ Board of Directors. Lyndal will enhance the board with a wealth of insight, experience, and expertise in the health and therapeutics space, all of which will help us achieve our strategic vision.
Lyndal Walker is currently the General Manager of Sun Pharma Canada’s Branded Business.
As General Manager, Walker oversees the company’s increasing market investment and expansion of its wide range of medicines, particularly in dermatology, ophthalmology and oncology. Walker is focused on optimizing the power of Sun Pharma’s people, innovative products, global network, and localized research, to accelerate Sun Pharma’s growth in Canada. With over 25 years of experience in global healthcare and the pharmaceutical industry, she continues to unlock value for Canadians and address the unmet needs and gaps in the healthcare system. Read more about Lyndal Walker
Ontario Genomics is also thankful to our retiring board members for their years of deep commitment to our board.
- Deb (Deborah) Stark served on our board for seven years and played an invaluable role as Chair of the board for five years. Deb brought a wealth of government and agriculture sector experience, while supporting vibrant board development and governance. We are especially grateful to Deb for her steady leadership throughout the challenges of the COVID-19 pandemic.
- Mark Lundie served on our board for six years and brought fantastic expertise in rare disease and a global pharmaceutical sector perspective. Mark greatly supported our private sector and commercialization programs.
- Jehoshua Sharma advanced our board with insights into the student perspective while supporting our training initiatives over the past four years. Thank you to our past board members for your contributions to OG!
To learn more about the new member and additional changes to our Board please see our governance page.